Open Access
Article
Alpha-Ketoglutarate and intestinal function
Yongqing Hou1,Lei Wang1,Binying Ding1,Yulan Liu1,Huiling Zhu1,Jian Liu1,Yongtang Li1,Ping Kang1,Yulong Yin1,Guoyao Wu1
1
Hubei key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan 430023, China. houyq777@yahoo.com.cn
DOI: 10.2741/3783 Volume 16 Issue 3, pp.1186-1196
Published: 01 January 2011
(This article belongs to the Special Issue Amino acids in nutrition, health, and disease)
Abstract

Alpha-ketoglutarate (AKG) is an intermediate of the Krebs cycle which bridges amino acid metabolism with glucose oxidation in animals. Of particular interest is the conversion of AKG into glutamate by mitochondrial glutamate dehydrogenase in the gastrointestinal tract where glutamate has multiple physiological functions (including regulation of cell function, neurotransmission, and gastric emptying). Additionally, AKG stimulates the initiation of catabolism of branched-chain amino acids (BCAA) via BCAA transaminase in enterocytes. Oxidation of AKG also provides large amounts of ATP and modulates cellular redox state in the small intestine. Translating the basic research into practice, results of recent studies indicate that dietary supplementation with AKG alleviates oxidative stress and injury in intestinal mucosal cells, while improving intestinal mucosal integrity and absorption of nutrients in endotoxin-challenged pigs. The beneficial effects of AKG are associated with increased activation of the mTOR signaling pathway and net protein synthesis. Thus, AKG is a novel and promising supplement in diets to improve intestinal health in animals and possibly humans.

Share and Cite
Yongqing Hou, Lei Wang, Binying Ding, Yulan Liu, Huiling Zhu, Jian Liu, Yongtang Li, Ping Kang, Yulong Yin, Guoyao Wu. Alpha-Ketoglutarate and intestinal function. Frontiers in Bioscience-Landmark. 2011. 16(3); 1186-1196.